Drug Database
Back to search

Netherlands· NL-98e472a3af0e

Corvert 87 µg/ml, oplossing voor intraveneuze infusie

A ibutilide product containing ibutilide fumaraat, registered in Netherlands by Pfizer B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC C01BD05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCorvert 87 µg/ml, oplossing voor intr…ATCC01BD05REGISTER NO.NL-98e472a3af0ePACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ibutilide fumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ibutilide is registered in 5 of 19 countries.

Countries holding a registration under ATC C01BD05 (ibutilide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose
Search ibutilide products by name

Ibutilide · ATC C01BD05

5 / 19 countries

  • Canada
  • Finlandprice
  • Netherlands
  • Norwayprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
IBUTILIDE FUMARAAT
Manufacturer
Pfizer B.V.
Country
Netherlands (NL)
ATC code
C01BD05
ATC class
Ibutilide
Defined daily dose
1 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    21286

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

175 interactions on record for ibutilide.

Graded by severity as the source publishes them — 131 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ibutilide against other medicinesHow interaction checks work

Ibutilide · interactions on record

175 records

  • 131 severe
  • 41 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ibutilide in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ibutilide products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Austria · Corvert
  • Finland · Corvert
  • Italy · Corvert

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/69fb4eca-70e5-4b4c-a9f8-b1269c7ff515
GET /v1/drugs/69fb4eca-70e5-4b4c-a9f8-b1269c7ff515?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h21286_smpc.pdf",
  "strength": null,
  "atc_label": "Ibutilide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21286",
  "excipients": [
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "IBUTILIDE FUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21286.pdf",
  "authorised_at": "1997/06/12",
  "procedure_number": "FI/H/1022/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21286",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about ibutilide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console